Revenue, FY 2026
In GBP, as reported.
#66 by revenue of 180 brands in the benchmark.
DOCS · LSE Main Market · UK
How Dr. Martens runs its business, at a glance: £765M in revenue in fiscal 2026 (-2.9%), compared with 30 other D2C-first brands on growth, margins and marketing. 10 fiscal years since 2017 from its annual reports.
The numbers that show how Dr. Martens runs: what it keeps from each sale, what it spends to win customers, and what is left. Each card shows the trend and where Dr. Martens ranks.
In GBP, as reported.
#66 by revenue of 180 brands in the benchmark.
Revenue against the year before
Below the D2C-first median (+4.1%). Grows faster than 28% of all 174 brands.
Left of each sale after product and delivery costs
Above the D2C-first median (54.6%). Higher margin than 83% of all 169 brands.
Share of revenue spent on marketing and advertising
Not enough years on record to draw a trend.
Not reported.
Gross margin minus marketing: what is left for the team, rent and profit
Not enough years on record to draw a trend.
Not reported.
Profit from operations, before interest and tax
Above the D2C-first median (+1.7%). More profitable than 74% of all 178 brands.
Dr. Martens: FY 2026. Trend lines: the last 10 fiscal years, dashed line the median D2C-first brand in the same year. Bars: where Dr. Martens sits among all 180 brands, from lowest to highest.
For every 100 Dr. Martens takes in: what the products cost to make and deliver, what goes to marketing, what runs the company, and what is left as profit.
Product and deliveryMarketingTeam, rent and other costsOperating profitLoss (costs above revenue)
Medians are worked out line by line, so their parts can add up to slightly more or less than 100. Product and delivery is revenue minus gross profit; how much shipping sits there differs by company.
Type in your own numbers to see where you stand against Dr. Martens, the median D2C-first brand, and all 180 brands.
| Metric | You | Dr. Martens | Gap | D2C-firstmedian | Among all brands |
|---|---|---|---|---|---|
| Revenue growth | – | -2.9% | – | +4.1% | – |
| Gross margin | – | 66.2% | – | 54.6% | – |
| Marketing spend | – | – | – | 16.4% | – |
| Headroom | – | – | – | 32% | – |
| Operating margin | – | +7.5% | – | +1.7% | – |
D2C-first brands of a similar size, side by side.
| Brand | Revenue | Growth | Gross margin | Marketing | Headroom | Op. margin |
|---|---|---|---|---|---|---|
| YETIYETI · US | $1.96B | +6.9% | 59.6% | – | – | +12.4% |
| Lands' EndLE · US | $1.32B | +0.4% | 48.6% | 16.4% | 32.2% | +0.5% |
| Dr. MartensDOCS · Europe | £765M | -2.9% | 66.2% | – | – | +7.5% |
| LovesacLOVE · US | $698M | +1.1% | 58.8% | 12.3% | 46.5% | +3.3% |
| YatsenYSG · US | CNY 4.3B | +26.7% | 78.2% | 66.4% | 11.8% | -4.3% |
| Duluth TradingDLTH · US | $551M | -8.6% | 58.3% | 10.3% | 48% | +1.7% |
| Westwing GroupWEW · Europe | €449M | +1.1% | 52.9% | 12.2% | 40.7% | +4.2% |
| PurplePRPL · US | $431M | -5.6% | 39.4% | 30.3% | 9.1% | -7.7% |
| D2C-first median30 brands | +4.1% | 54.6% | 16.4% | 32% | +1.7% |
The 7 D2C-first brands closest to Dr. Martens in revenue. Green: above the median, grey: below. Revenue in each company's own currency.
Every fiscal year on record, in GBP. Point at a bar for growth and margins.
| Fiscal year | Revenue | Growth | Gross margin | Marketing | Op. margin | Net margin | Source |
|---|---|---|---|---|---|---|---|
| 2026ends 2026-03-29 | £765M | -2.9% | 66.2% | – | +7.5% | +3.1% | FY26 results statement |
| 2025ends 2025-03-30 | £788M | -10.2% | 65% | – | +4.7% | +0.6% | FY26 results statement |
| 2024ends 2024-03-31 | £877M | -12.3% | 65.6% | – | +13.9% | +7.9% | FY26 results statement |
| 2023ends 2023-03-31 | £1B | +10.1% | 61.8% | – | +17.6% | +12.9% | FY26 results statement |
| 2022ends 2022-03-31 | £908M | +17.5% | 63.7% | – | +25.2% | +19.9% | FY26 results statement |
| 2021ends 2021-03-31 | £773M | +15% | 60.9% | – | +14.4% | +4.5% | FY25 preliminary results |
| 2020ends 2020-03-31 | £672M | +47.9% | 59.7% | – | +21.2% | +11.1% | FY24 results statement |
| 2019ends 2019-03-31 | £454M | +30.3% | 57.3% | – | +15% | +3.8% | IPO Prospectus |
| 2018ends 2018-03-31 | £349M | +20% | 53.4% | – | +11.5% | -1.6% | IPO Prospectus |
| 2017ends 2017-03-31 | £291M | – | 51.2% | – | +10.7% | – | FY21 results statement |
Every figure is from Dr. Martens's annual reports and results releases; each year links to its document. Amounts in GBP.
Marketing is whatever the company reports as marketing, advertising or selling and marketing, so definitions differ between companies. Rankings compare each brand's latest 12 months (US) or latest fiscal year (Europe).
Notes on this data: All figures from Dr. Martens IR documents (results statements, IPO prospectus); reported in GBP millions to one decimal, converted to full units. Gross profit = company's 'gross margin' line (revenue less cost of sales). operating_income = statutory EBIT (company APM equal to profit before net finance expense), not adjusted EBIT. EBITDA is a company APM: FY17-FY21 figures are before exceptional items; FY22-FY24 had no exceptional items; FY25-FY26 EBITDA (from FY25/FY26 statements) is not adjusted for exceptional costs. FY17-FY19 are pre-IFRS 16. Marketing spend is not disclosed as an amount (only 'demand generation' commentary), so null. Active customers not reported. FY17 net income not found in company documents (prospectus covers FY18-FY20 only).
Bratrax connects to your Shopify store and ad accounts and shows you the numbers that decide whether you're making money: profit after ad spend and product costs, which channels bring customers who come back, and where your next dollar should go.
$1 first month · then $99/month flat · no contract